Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Global Paradise System US Post Approval Study

View source ↗

Summary

Ongoing US post-approval study for the Paradise Renal Denervation System by ReCor Medical, currently recruiting to evaluate safety and effectiveness in hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ReCor Medical, Inc. | Conditions: Hypertension, Cardiovascular Diseases | Status: RECRUITING